Friday, September 25, 2020

Granules India gets USFDA nod for sleep aid drug

Granules India gets USFDA nod for sleep aid drug The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, 220 mg/25 mg (OTC), Granules said in a BSE filing.

from Moneycontrol Business News https://ift.tt/367wwdq
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...